Publications by authors named "Nancy Levin"

Claim this Profile
M
Marizomib alone or in combination with bevacizumab in patients with recurrent glioblastoma: Phase I/II clinical trial data.
Daniela A Bota, Warren Mason, Santosh Kesari, Rajiv Magge, Benjamin Winograd, Nancy Levin

Neurooncol Adv· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline mutations in apoptosis pathway genes in ovarian cancer; the functional role of a TP53I3 (PIG3) variant in ROS production and DNA repair.
Sophia R Chaudhry, Jaime Lopes, Nancy K Levin, Hasini Kalpage, Michael A Tainsky

Cell Death Discov· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of paraneoplastic antigens reveals TRIM21 autoantibodies as biomarker for early detection of ovarian cancer in combination with autoantibodies to NY-ESO-1 and TP53.
Laura C Hurley, Nancy K Levin, Madhumita Chatterjee, Jasmine Coles, Shlomo Muszkat

Cancer Biomark· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FANCM, RAD1, CHEK1 and TP53I3 act as BRCA-like tumor suppressors and are mutated in hereditary ovarian cancer.
Jaime L Lopes, Sophia Chaudhry, Guilherme S Lopes, Nancy K Levin, Michael A Tainsky

Cancer Genet· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance.
Batoul Farran, Samet Albayrak, Judith Abrams, Michael A Tainsky, Nancy K Levin

Cancer Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma (NPI-0052-107): final study results.
Andrew Spencer, Simon Harrison, Jeffrey Zonder, Ashraf Badros, Jacob Laubach, Nancy Levin

Br J Haematol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.
Renger G Tiessen, Ciara A Kennedy, Bradley T Keller, Nancy Levin, Lisette Acevedo

BMC Gastroenterol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of paraneoplastic antigens as biomarkers for surveillance and prediction of recurrence in ovarian cancer.
Madhumita Chatterjee, Laura C Hurley, Nancy K Levin, Matthew Stack, Michael A Tainsky

Cancer Biomark· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability.
Jaime L Stafford, Gregory Dyson, Nancy K Levin, Sophia Chaudhry, Rita Rosati

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients.
Nancy Levin, Andrew Spencer, Simon J Harrison, Dharminder Chauhan, Francis J Burrows

Br J Haematol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bitter pill for type 2 diabetes? The activation of bitter taste receptor TAS2R38 can stimulate GLP-1 release from enteroendocrine L-cells.
Hung Pham, Hongxiang Hui, Susan Morvaridi, Jiena Cai, Sanqi Zhang, Nancy Levin

Biochem Biophys Res Commun· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
Zahava Vadasz, Yair Goldeberg, Katty Halasz, Itzhak Rosner, Guido Valesini, Nancy Agmon Levin

Clin Immunol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance.
Barbara Bernardo, Min Lu, Gautam Bandyopadhyay, Pingping Li, Yingjiang Zhou, Nancy Levin

Sci Rep· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive markers of efficacy for an angiopoietin-2 targeting therapeutic in xenograft models.
Gallen Triana-Baltzer, Adam Pavlicek, Ariadne Goulart, Hanhua Huang, Steven Pirie-Shepherd, Nancy Levin

PLoS One· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet-induced obesity.
José L Walewski, Fengxia Ge, Harrison Lobdell, Nancy Levin, Gary J Schwartz

Obesity (Silver Spring)· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel long-acting antidiabetic FGF21 mimetic by targeted conjugation to a scaffold antibody.
Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F Osothprarop, Nancy Levin

J Pharmacol Exp Ther· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor autoantibodies as biomarkers for predicting ovarian cancer recurrence.
Madhumita Chatterjee, Greg Dyson, Nancy K Levin, Jay P Shah, Robert Morris

Cancer Biomark· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variants in the Signaling Protein TSAd are Associated with Susceptibility to Ovarian Cancer in BRCA1/2 Negative High Risk Families.
Ludmila Kaplun, Aviva Levine Fridman, Wei Chen, Nancy K Levin, Sidra Ahsan

Biomark Insights· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloperoxidase and free iron levels: potential biomarkers for early detection and prognosis of ovarian cancer.
Nicole M Fletcher, Zhongliang Jiang, Rouba Ali-Fehmi, Nancy K Levin, Jimmy Belotte

Cancer Biomark· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults.
Yinon Shapira, Bat-Sheva Poratkatz, Boris Gilburd, Ori Barzilai, Maya Ram, Nancy Agmon Levin

Clin Rev Allergy Immunol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor efficacy of a thrombospondin 1 mimetic CovX-body.
Lingna Li, Tom A Leedom, Janet Do, Hanhua Huang, JingYu Lai, Nancy J Levin

Transl Oncol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth.
Hanhua Huang, Jing-Yu Lai, Janet Do, Dingguo Liu, Lingna Li, Nancy Levin

Clin Cancer Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of potent and stable placental-growth-factor-1-targeting CovX-bodies from phage display peptide discovery.
Kristen E Bower, Son N Lam, Bryan D Oates, Joselyn R Del Rosario, Emily Corner, Nancy J Levin

J Med Chem· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical generation of bispecific antibodies.
Venkata R Doppalapudi, Jie Huang, Dingguo Liu, Ping Jin, Bin Liu, Nancy J Levin

Proc Natl Acad Sci U S A· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined use of immunoassay and two-dimensional liquid chromatography mass spectrometry for the detection and identification of metabolites from biotherapeutic pharmacokinetic samples.
Robert E Murphy, Arvind G Kinhikar, Michael J Shields, Joselyn Del Rosario, Ryan Preston, Nancy Levin

J Pharm Biomed Anal· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis